URGN UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies.

As of 12/03/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  Israel
IPO date:  05/04/2017
Outstanding shares:  22,420,325
Average volume:  176,145
Market cap:   $267,698,681
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    M96088105
ISIN:        IL0011407140
Sedol:      BZ7PJQ1
Valuation   (See tab for details)
PE ratio:   -2.28
PB ratio:   8.16
PS ratio:   6.72
Return on equity:   -357.97%
Net income %:   -283.41%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy